Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dyne Therapeutics Inc (DYN)

Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,896,747
  • Shares Outstanding, K 87,383
  • Annual Sales, $ 0 K
  • Annual Income, $ -235,940 K
  • 60-Month Beta 1.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.96
Trade DYN with:

Options Overview Details

View History
  • Implied Volatility 39.80% ( -22.15%)
  • Historical Volatility 87.51%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 350.04% on 11/10/23
  • IV Low 39.80% on 06/18/24
  • Put/Call Vol Ratio 0.19
  • Today's Volume 44
  • Volume Avg (30-Day) 227
  • Put/Call OI Ratio 1.77
  • Today's Open Interest 12,305
  • Open Int (30-Day) 12,052

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.73
  • Number of Estimates 8
  • High Estimate -0.59
  • Low Estimate -0.97
  • Prior Year -1.08
  • Growth Rate Est. (year over year) +32.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.41 +12.72%
on 05/29/24
35.98 -7.87%
on 05/21/24
+5.47 (+19.76%)
since 05/17/24
3-Month
23.11 +43.44%
on 04/19/24
35.98 -7.87%
on 05/21/24
+6.87 (+26.14%)
since 03/18/24
52-Week
6.40 +417.97%
on 10/30/23
35.98 -7.87%
on 05/21/24
+22.20 (+202.74%)
since 06/16/23

Most Recent Stories

More News
Why Shares of Dyne Therapeutics Fell This Week

Insiders sold more than 15,000 shares of company stock on Tuesday.

DYN : 33.15 (+4.28%)
Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics

Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics are part of the Zacks Industry Outlook article.

DYN : 33.15 (+4.28%)
ACER : 0.6601 (-17.95%)
ASRT : 1.1000 (+4.76%)
SLN : 18.90 (-0.53%)
TCRT : 0.8301 (-13.53%)
5 Stocks to Buy as the Drug Industry Bets Big on Innovation

Innovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, TCRT, ASRT and ACER may prove to be good additions to one's portfolio.

DYN : 33.15 (+4.28%)
ACER : 0.6601 (-17.95%)
ASRT : 1.1000 (+4.76%)
SLN : 18.90 (-0.53%)
TCRT : 0.8301 (-13.53%)
All You Need to Know About Dyne Therapeutics, Inc. (DYN) Rating Upgrade to Strong Buy

Dyne Therapeutics, Inc. (DYN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DYN : 33.15 (+4.28%)
Does Dyne Therapeutics, Inc. (DYN) Have the Potential to Rally 84% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 84% in Dyne Therapeutics, Inc. (DYN). While the effectiveness of this highly sought-after metric is questionable,...

DYN : 33.15 (+4.28%)
Here's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now

Dyne Therapeutics, Inc. (DYN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement...

DYN : 33.15 (+4.28%)
Wall Street Analysts Predict a 141% Upside in Dyne Therapeutics, Inc. (DYN): Here's What You Should Know

The mean of analysts' price targets for Dyne Therapeutics, Inc. (DYN) points to a 141% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among...

DYN : 33.15 (+4.28%)
Dyne Therapeutics Announces “Breakthrough Article” Publication of Duchenne Muscular Dystrophy Program Data in Nucleic Acids Research

- FORCE™ Platform Achieves Enhanced Exon Skipping and Prolonged Dystrophin Restoration in Duchenne in vivo mdx Model - WALTHAM, Mass., Aug. 10, 2022 ...

DYN : 33.15 (+4.28%)
Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

- Initiation of Patient Dosing in Multiple Ascending Dose Clinical Trials for DYNE-251 in DMD and DYNE-101 in DM1 On Track for Mid-2022 - WALTHAM, Mass.,...

DYN : 33.15 (+4.28%)
Best Momentum Stocks to Buy for July 18th

DINO, DYN, and DLNG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 18, 2022.

DYN : 33.15 (+4.28%)
DLNG : 3.60 (-4.00%)
DINO : 52.14 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dyne Therapeutics Inc. is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The company's proprietary platform includes FORCE(TM). Dyne Therapeutics Inc. is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 35.96
2nd Resistance Point 34.74
1st Resistance Point 33.95
Last Price 33.15
1st Support Level 31.94
2nd Support Level 30.72
3rd Support Level 29.93

See More

52-Week High 35.98
Last Price 33.15
Fibonacci 61.8% 24.68
Fibonacci 50% 21.19
Fibonacci 38.2% 17.70
52-Week Low 6.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar